173 related articles for article (PubMed ID: 29524401)
1. Ablation of prolactin receptor increases hepatic triglyceride accumulation.
Shao S; Yao Z; Lu J; Song Y; He Z; Yu C; Zhou X; Zhao L; Zhao J; Gao L
Biochem Biophys Res Commun; 2018 Apr; 498(3):693-699. PubMed ID: 29524401
[TBL] [Abstract][Full Text] [Related]
2. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
Zhang M; Sun W; Zhou M; Tang Y
Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
7. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
Elife; 2023 Aug; 12():. PubMed ID: 37580962
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice.
Tao L; Guo X; Xu M; Wang Y; Xie W; Chen H; Ma M; Li X
Pharmacol Res Perspect; 2021 Feb; 9(1):e00700. PubMed ID: 33474802
[TBL] [Abstract][Full Text] [Related]
9. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
11. Vitamin A deficiency suppresses high fructose-induced triglyceride synthesis and elevates resolvin D1 levels.
Raja Gopal Reddy M; Pavan Kumar C; Mahesh M; Sravan Kumar M; Mullapudi Venkata S; Putcha UK; Vajreswari A; Jeyakumar SM
Biochim Biophys Acta; 2016 Mar; 1861(3):156-65. PubMed ID: 26597784
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
13. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
14. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
15. Tussilagone ameliorates high-fat diet-induced hepatic steatosis by enhancing energy metabolism and antioxidant activity.
Sun M; Li Y; Su S; Gao J; Yu L; Qi X; Liang H; Li X; Qi X; Liang Y; Zhou L; Zhang G; Li Y
Phytother Res; 2024 May; 38(5):2099-2113. PubMed ID: 37010930
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
17. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
18. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG
World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651
[TBL] [Abstract][Full Text] [Related]
19. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
20. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice.
Ling C; Hellgren G; Gebre-Medhin M; Dillner K; Wennbo H; Carlsson B; Billig H
Endocrinology; 2000 Oct; 141(10):3564-72. PubMed ID: 11014209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]